UiPath Inc. (PATH)

NEW YORK--(BUSINESS WIRE)--UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced it will report financial results for its first quarter fiscal 2026 ended April 30, 2025 aft...

With PATH stock recovering after a decline, we assess its current status to decide on the best strategy for the future.

The Zacks Internet-Software Industry is currently in the top 33% of almost 240 Zacks industries and has a plethora of stocks that have made their way onto the Zacks Rank #1 (Strong Buy) list.

UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

UiPath's kitchen sink FY2026 guidance has triggered growth concerns after the robust 3Y top/bottom-line performance, with it contributing to the massive selloff thus far. This is worsened by the poten...

The best way to grow your wealth and better prepare yourself for retirement is to invest your money in promising stocks. Growth stocks are a great bet for the future and can help you increase the valu...

UiPath (PATH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Despite a 20% stock decline, we maintain a bullish view on UiPath due to its strategic pivot to Agentic AI and strong customer retention. PATH leads the growing RPA market, with robust demand and a co...

Both APP and PATH are technology companies leveraging artificial intelligence to enhance their platforms. Which one is a better investment?

NEW YORK & LAS VEGAS--(BUSINESS WIRE)--UiPath announced the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by Google Cloud Vertex AI and Gemini models.